Tirzepatide becoming a twin GLP-one and GIP agonist, it is actually suggested that the GIP part of dual agonism could be liable for the additional benefit, presented the likely benefit of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was more effective than dulaglutide in lowering fasting dietary TAG [six,seven].